Background: Different MRI parameters have been studied for evaluating thyroid nodules. Diffusion-weighted imaging (DWI) and T2 imaging sequences with considerable efficacy in evaluating soft tissue tumors merit further assessment for thyroid nodule investigation.

Method: We evaluated incidental thyroid nodules (ITNs) reported on head and neck MRI studies. The T2 signal intensity (SI), T2 signal intensity ratio (SIR), value, and apparent diffusion coefficient (ADC) values of the thyroid nodule were obtained for every patient. The patients were referred to the radiology department for the thyroid nodule ultrasound study. Finally, 33 participants (37 thyroid nodules) who were scheduled for fine needle aspiration and cytology (FNAC) were enrolled. Regarding the FNAC results, the nodules were divided into malignant and benign groups. The two groups' MRI parameters were compared using a two samples independent test, and the cutoff values were estimated by analyzing the receiver operating characteristics plot.

Results: The T2 signal intensities, SIR, values, and ADC values were significantly higher in the benign group than malignant. The cutoff points of 230 (AUC = 0.759), 3.38 (AUC = 0.754), 37 (AUC = 0.759), and 1.73 (AUC = .690) were obtained for T2 values, SIR, values, and ADC values, respectively.

Conclusion: T2, SIR, , and ADC values are reliable for discriminating benign from malignant ITNs. However, further studies with a larger sample size are needed to provide more accurate mean values, identify outliers, and reduce confounding factors and bias.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579554PMC
http://dx.doi.org/10.1007/s42399-022-01307-wDOI Listing

Publication Analysis

Top Keywords

thyroid nodules
16
adc values
16
mri parameters
12
thyroid nodule
12
values
9
incidental thyroid
8
signal intensity
8
sir values
8
values adc
8
thyroid
7

Similar Publications

Introduction Thyroid malignancy remains a significant global health concern, making the accurate differentiation between benign and malignant thyroid nodules crucial for optimal patient management. Fine-needle aspiration cytology (FNAC) is the gold-standard preoperative diagnostic tool, and The Bethesda System for Reporting Thyroid Cytopathology provides a standardized framework for interpretation. This 10-year retrospective study evaluated the malignancy risk in surgically treated patients with thyroid nodules classified as Bethesda Category III by comparing FNAC findings with histopathological outcomes.

View Article and Find Full Text PDF

Background: Ultrasound based radiomics prediction model can improve the differentiation ability of benign and malignant thyroid nodules to avoid overtreatment. This study evaluates the role of predictive models based on intranodular and perinodular ultrasound radiomics in distinguishing between benign and malignant thyroid nodules.

Methods: A total of 1,076 thyroid nodules were enrolled from three hospitals between 2016 and 2022, forming the training, validation and test cohorts.

View Article and Find Full Text PDF

Background: When papillary thyroid carcinoma (PTC) is accompanied by Hashimoto's thyroiditis (HT), it is often challenging for preoperative ultrasound to distinguish between central lymph node enlargement caused by PTC metastasis and inflammatory reaction due to HT. However, central lymph node metastasis (CLNM) is closely associated with the risk of PTC recurrence after surgery. In this study, we developed a model to predict in patients with PTC combined with HT, based on conventional ultrasound characteristics and shear wave elastography (SWE) quantitative parameters of the primary lesion.

View Article and Find Full Text PDF

Background: Differentiated thyroid carcinoma (DTC) is the most common pediatric thyroid malignancy, with papillary thyroid carcinoma (PTC) representing 90% of the cases. In 2015, the American Thyroid Association (ATA) developed management guidelines for pediatric DTC.

Procedure: Patients less than 21 years of age diagnosed with DTC between 2000 and 2015 at Texas Children's Hospital, Seattle Children's Hospital, Children's Healthcare of Atlanta, Children's Hospital Colorado, and Nationwide Children's Hospital were retrospectively analyzed to evaluate treatment practices before the implementation of the ATA guidelines.

View Article and Find Full Text PDF

There has been remarkable growth in our understanding of the biologic behavior and molecular signature of thyroid malignancies, which has led to the introduction, application, and evolution of molecular testing of thyroid nodule FNA cytology. Next-generation sequencing molecular testing is an important, well-validated diagnostic tool for management of cytologically indeterminate thyroid nodules. It reduces unnecessary thyroid surgery for benign disease, avoiding associated surgical risks for the patient and reducing healthcare expenses.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!